drugset / Trial / NCT03471910
Clinical Non-inferiority Study Between Diosmin 600mg & Diosmin + Hesperidin in Symptomatic Chronic Venous Insufficiency
RandomizedParallel-groupTriple-blindTreatment
Summary
Clinical non-inferiority study between Diosmin 600 mg tablets and Diosmin 900 mg + Hesperidin 100 mg tablets in symptomatic chronic venous insufficiency after 6 months of treatment. Prospective, single-blind, randomized study in parallel groups (total patient population 120, 60 subjects per treatment group), with a total of 4 clinical assessment at months 0, 2, 4, and 6 of treatment.
Timeline
- Start
- 2017-06-20
- Primary completion
- 2018-03-20
- Completion
- 2018-04-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Diosmin | Small molecule | 600 mg | — |
| Subject | Diosmin | Small molecule | 900 mg | — |
| Comparator | Hesperidin | Small molecule | 100 mg | — |